##semicolon##
arterial hypertension, overweight, obesity, metabolic syndrome, coronary heart disease.##submission.citations##
1. Al Adawi, R.M., Stewart, D., Ryan, C. et al. A systematic review of pharmacist input to metabolic syndrome screening, management and prevention. Int J Clin Pharm. 2020; 42:995–1015. https://doi.org/10.1007/s11096-020-01084-3
2. A Call to Action on Diabetes. International Diabetes Federation, November 2010. www.idf.org
3. Belete, R. et al. Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021; 13:25.
4. Emiral, G.O. et al. Metabolic syndrome prevalence and related factors in a Turkish adult population. Niger J Clin Pract. 2021; 24:28–37.
5. Hsu, C.H., Lin, J.D., Hsieh, C.H. et al. Body mass index, metabolic syndrome and carotid atherosclerosis. Nutr Res. 2014;34(3):219–225. https://doi.org/10.1016/j.nutres.2014.01.004
6. Huang, Y., Wang, S., Cai, X., Mai, W., Hu, Y., Tang, H., Xu, D. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013; 11:177. https://doi.org/10.1186/1741-7015-11-177
7. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Obesity and Metabolism. 2005;2(3):47–49.
8. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation; 2017.
9. Kalandarova, U.A., Ibadova, M.U., Ismatova, M.N., Kayumov, N.U. Dynamics of the levels of metabolic syndrome components in different types of hyperglycemias. J Biomed Pract. 2019;1(1):72–78.
10. Kayumov, U.K., Kalandarova, U.A., Ibadova, M.U., Ismatova, M.N. The formation of a hard “end point” for various risk factors. J Biomed Pract. 2019;1(1):79–84.
11. Kayumov, U.K., Kalandarova, U.A., Ibragimov, A.Yu., Saipova, M.L. The prevalence of ischemic heart disease and mortality from this disease at various components of metabolic syndrome. New Day in Medicine. 2019;3(27):138–141.
12. Kayumov, U.K., Matmuratova, S.O., Khatamova, D.T. et al. The combination of components of the metabolic syndrome in women of childbearing age and their relationship with age. Cent Asian J Med Nat Sci. 2022;3(6):84–87. https://cajmns.centralasianstudies.org/index.php/ CAJMNS/article/view/1172
13. Liu, P.J., Lou, H.P., Zhu, Y.N. Screening for metabolic syndrome using an integrated continuous index consisting of waist circumference and triglyceride: a preliminary cross-sectional study. Diabetes Metab Syndr Obes. 2020; 13:2899–2907. https://doi:10.2147/DMSO.S259770
14. Lucchetti, B.F.C., Boaretto, N., Lopes, F.N.C. et al. Metabolic syndrome aggravates cardiovascular, oxidative and inflammatory dysfunction during the acute phase of Trypanosoma cruzi infection in mice. Sci Rep. 2019; 9:18885. https://doi.org/10.1038/s41598-019-55363-9
15. McCracken, E., Monaghan, M., Sreenivasan, S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36(1):14–20. https://doi.org/10.1016/j.clindermatol.2017.09.004
16. Otamas, A., Grant, P.J., Ajjan, R.A. Diabetes and atherothrombosis: the circadian rhythm and role of melatonin in vascular protection. Diabetes Vasc Dis Res. 2020;17(3). https://doi.org/10.1177/1479164120920582
17. Rose, G.A., Blackburn, H. Cardiovascular Survey Methods. Monogr Ser World Health Organ. 1968; 56:1–188. PMID: 4972212.
18. Tu, D., Li, P., Li, K. Metabolic health and cardiovascular disease across BMI categories: NHANES findings. J Health Popul Nutr. 2025; 44:273. https://doi.org/10.1186/s41043-025-01003-0
19. Zablith, N., Diaconu, K., Naja, F. et al. Dynamics of non-communicable disease prevention, diagnosis and control in Lebanon, a fragile setting. Confl Health. 2021; 15:4. https://doi.org/ 10.1186/s13031-020-00337-2